Figure 6 demonstrates intensive PSMA-ligand uptake in multiple bone and lymph node metastases with mean SUVmean 14.7 (range 9.2–19) and mean SUVmax 21.6 (range 15.4–28.2). This evidence concerns the gene FOLH1 and metastatic malignant neoplasm in the lymph nodes.